Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics Market Cap

Anika Therapeutics has a market cap or net worth of $254.69 million as of February 21, 2025. Its market cap has decreased by -25.73% in one year.

• Market Cap: 254.69M
• Enterprise Value: 219.85M
• 1-Year Change: -25.73%
• Ranking: #3481
• Category: Micro-Cap
• Stock Price: $17.39

Market Cap Chart

Since December 1, 1998, Anika Therapeutics's market cap has increased from $51.20M to $254.69M, an increase of 397.44%. That is a compound annual growth rate of 6.30%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2025	258.50M	7.22%
Dec 31, 2024	241.10M	-27.34%
Dec 29, 2023	331.80M	-23.27%
Dec 30, 2022	432.40M	-16.41%
Dec 31, 2021	517.30M	-19.59%
Dec 31, 2020	643.30M	-13.06%
Dec 31, 2019	739.90M	54.92%
Dec 31, 2018	477.60M	-39.57%
Dec 29, 2017	790.40M	10.39%
Dec 30, 2016	716.00M	28.18%
Dec 31, 2015	558.60M	-5.47%
Dec 31, 2014	590.90M	12.00%
Dec 31, 2013	527.60M	284.27%
Dec 31, 2012	137.30M	2.85%
Dec 30, 2011	133.50M	48.50%
Dec 31, 2010	89.90M	2.98%
Dec 31, 2009	87.30M	152.31%
Dec 31, 2008	34.60M	-78.71%
Dec 31, 2007	162.50M	14.12%
Dec 29, 2006	142.40M	16.06%
Dec 30, 2005	122.70M	31.51%
Dec 31, 2004	93.30M	-4.11%
Dec 31, 2003	97.30M	892.86%
Dec 31, 2002	9.80M	-1.01%
Dec 31, 2001	9.90M	26.92%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	784.71B
UnitedHealth Group	429.24B
Novo Nordisk	391.83B
Johnson & Johnson	390.76B
AbbVie	356.74B
Abbott Laboratories	234.01B
AstraZeneca	229.50B
Merck & Co.	226.40B